The Centers for Medicare & Medicaid Services (CMS) will allow Michigan’s Medicaid program to enter into outcomes-based drug payments with manufacturers. It’s the second state to receive approval from the agency to move forward with such arrangements.
CMS approves value-based drug payments in Michigan’s Medicaid program
